An unknown buyer agreed to acquire Revlis Biotech Co., Ltd. from Coland Holdings Limited (TSEC:4144) for TWD 70 million on March 24, 2017. Under the terms of agreement, 2 million shares shall be acquired for TWD 35 per share. In a related transaction, Coland Holdings Limited sold Hung Chun Bio-S Tech Co., Ltd., and CDIB Healthcare Fund Ltd. Central Chief Limited sold Joinsmart Biomedical Co., Ltd. The transaction is subject to approval by the relevant organization in charge in Taiwan. An unknown buyer cancelled the acquisition of Revlis Biotech Co., Ltd. from Coland Holdings Limited (TSEC:4144) on March 24, 2018.